A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

Weight-loss medicines such as Ozempic might raise a person’s likelihood of developing conditions including arthritis.

Amgen Inc . (NASDAQ:AMGN), a leading biopharmaceutical company with a market capitalization of $149 billion, is navigating a ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

Obesity can put strain on the heart, resulting in an increased risk of conditions such as atrial fibrillation, or irregular ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

An international team of doctors proposed a new way to define obesity that's not based solely on BMI. Here's what they ...

The Lancet Commission has declared obesity a disease. With enough controversy to fill a buffet table, their new definition is ...

Waist circumference and waist-to-hip ratio show stronger links to colorectal cancer (CRC) than body mass index (BMI), a new ...

Body Mass Index, or BMI, has long been criticized as an unreliable method for measuring obesity — and now a group of experts ...

Obesity, long determined by the flawed metric of BMI, should be diagnosed based on other measurements, experts argue.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but without diabetes, according to a study published online Jan. 21 in JAMA Network ...